Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Best ETFs for 2020: The Alternative Harvest ETF (MJ) Will Light Up

The Alternative Harvest ETF (MJ) has a shot at being one of the best ETFs next year, as its holdings should bounce off their all-time lows.

3 Excellent Reasons to Be Bullish on Aphria

It’s been horrific for cannabis stocks. But Aphria stock is presenting some interesting opportunities. Here’s a look at this standout company.

Hexo? Heck No! Just Avoid Hexo Stock for Now

I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.

Tuesday’s Vital Data: Freeport-McMoRan, Canopy Growth and Aurora Cannabis

Options trading was buzzing in Freeport-McMoRan, Canopy Growth and Aurora Cannabis. Here are the metrics that matter moving forward.

Aphria Is Making the Right Moves to Survive Marijuana Slump

The outlook for cannabis stocks remains challenging. But if anyone can turn it around in 2020, it could well be Aphria.

If You Haven’t Ditched NBEV Stock Yet, Now Is the Time

New Age Beverages stock is a multi-level marketing loser. The CEO is selling shares and the company is in debt and losing money.

5 Reasons to Buy Aphria Stock Before Pot Stocks Start Moving Again

Like other Canadian cannabis stocks, APHA stock has taken a beating in recent months as revenue growth has fallen short of expectations. However, there are at least five reasons why Aphria shares could be headed higher soon.

Is the Right Move to Buy Hexo Stock Amid Cannabis Rebound?

Hexo stock is showing improvement on the charts, but we need a significant improvement given the lacking fundamentals and industry disdain.

Cannabis 2.0 Highlights the Rewards — and Risks — of Canopy Growth Stock

Cannabis 2.0 is supposed to give Canopy Growth stock an edge over other cannabis plays. But if Cannabis 2.0 is disappointing, CGC stock will be out of catalysts.

7 Lumbering Large-Cap Stocks to Avoid

The U.S.-China trade war is weighing on these large-cap stocks to sell. Volatile oil prices and the opioid crisis aren't helping, either.

The Outlook of Aurora Stock Is Mixed

Aurora stock is out of favor and is at risk of falling steadily over the next few quarters. But the long-term outlook of ACB stock is upbeat.

10 Hot Pot Stocks to Buy

When pot stocks failed to live up to heightened expectations, investors panicked out of the sector. However, the selloff has probably gone on far too long, suggesting a possible comeback.

A Constellation Buyout Would Harm Canopy Growth Shareholders

Canopy Growth, like other marijuana stocks, continues trending downward. One big factor could prevent it from recovering.

Why Canopy Growth Stock Could Rebound Tremendously in 2020

While 2019 was a rough year for Canopy Growth stock, CGC stock could nearly double in 2020.

Aurora Cannabis Stock Offers Traders Fresh Opportunities

Cannabis stocks are struggling to gain traction but trading opportunities are still available. Aurora stock wants to base to setup rallies.

5 Under-the-Radar Marijuana Stocks With Over 100% Upside

With the U.S. taking one step closer towards decriminalization, I set out to find marijuana stocks that have been flying under the radar.

What the MORE Act Means for Cannabis Stocks

The MORE Act is one of two marijuana bills making their way through Congress. The MORE Act is good news for the legalization effort, but it likely won't be a game-changer for cannabis stocks.

6 Giant Investing Trends for 2020 That You Don’t Want to Miss

These investing trends for 2020 cover trends that will disrupt everything from the housing market to the cars we drive. Don't miss out.

Ignore the Canopy Growth Ambulance Chasers

On Nov. 21, Canopy Growth responded to the potential class-action suits. CGC stock fell on the news. Should shareholders be concerned?

Aphria Stock May Be Headed Higher, But It’s Too Soon to Tell

Canadian cannabis producer Aphria hit an all-time low of $3.76 Nov. 19. Since then, Aphria stock has recovered nicely. Is that the bottom?